Skip to main content
Erschienen in: European Radiology 11/2017

18.05.2017 | Oncology

Evaluation of renal cell carcinoma histological subtype and fuhrman grade using 18F-fluorodeoxyglucose-positron emission tomography/computed tomography

verfasst von: Reiko Nakajima, Sayumi Nozaki, Tsunenori Kondo, Yoji Nagashima, Koichiro Abe, Shuji Sakai

Erschienen in: European Radiology | Ausgabe 11/2017

Einloggen, um Zugang zu erhalten

Abstract

Objectives

We evaluated 18F-fluorodeoxyglucose (FDG) uptake by renal cell carcinomas (RCCs) to determine whether different histological subtypes and Fuhrman grades can be distinguished.

Methods

We retrospectively reviewed the records and maximum standardised uptake value (SUVmax) of 147 patients with 154 RCCs who underwent FDG-positron emission tomography (PET)/computed tomography (CT) prior to tumour resection.

Results

The SUVmax was significantly lower in chromophobe RCC (chRCC) tumours than in clear cell RCC (ccRCC; p = 0.003) and papillary RCC (pRCC; p = 0.034) tumours. The mean tumour SUVmax was 4.58 ± 4.1 (range, 1.29–30.4) for ccRCC, 3.98 ± 1.9 (range, 0.49–6.72) for pRCC, and 1.93 ± 0.9 (range, 0.89–3.41) for chRCC. The SUVmax was not significantly different between the ccRCC and pRCC groups. In ccRCC and pRCC tumours, high-grade tumours had a significantly greater SUVmax (p < 0.001 and p < 0.05) than low-grade tumours by analysis of variance (ANOVA) and the Mann-Whitney U test. In ccRCC, multivariate regression analysis indicated that the SUVmax was a significant indicator of Fuhrman grade. No significant differences in uptake were observed between high- and low-grade chRCC tumours.

Conclusions

The SUVmax obtained using FDG-PET/CT may be an important indicator for predicting tumour grade in ccRCC and pRCC.

Key Points

FDG accumulation reflects tumour aggressiveness and correlates with Fuhrman grade.
FDG-PET/CT enables the differentiation of high- and low-grade ccRCC and pRCCs.
FDG-PET/CT may valuable in the identification of some high-grade RCCs.
Literatur
1.
Zurück zum Zitat Hoekstra CJ, Stroobants SG, Hoekstra OS et al (2003) The value of [18F] fluoro-2-deoxy-D glucose positron emission tomography in the selection of patients with stage IIIA-N2 non- small cell lung cancer for combined modality treatment. Lung Cancer 39:151–157CrossRef Hoekstra CJ, Stroobants SG, Hoekstra OS et al (2003) The value of [18F] fluoro-2-deoxy-D glucose positron emission tomography in the selection of patients with stage IIIA-N2 non- small cell lung cancer for combined modality treatment. Lung Cancer 39:151–157CrossRef
2.
Zurück zum Zitat Takahashi M, Kume H, Koyama K et al (2015) Preoperative evaluation of renal cell carcinoma by using 18F-FDG-PET/CT. Clin Nucl Med 40:936–940CrossRef Takahashi M, Kume H, Koyama K et al (2015) Preoperative evaluation of renal cell carcinoma by using 18F-FDG-PET/CT. Clin Nucl Med 40:936–940CrossRef
3.
Zurück zum Zitat Aide N, Cappele O, Bottet P et al (2003) Efficiency of [18F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT. Eur J Nucl Med Mol Imaging 30:1236–1245CrossRef Aide N, Cappele O, Bottet P et al (2003) Efficiency of [18F]FDG PET in characterising renal cancer and detecting distant metastases: a comparison with CT. Eur J Nucl Med Mol Imaging 30:1236–1245CrossRef
4.
Zurück zum Zitat Ozülker T, Ozülker F, Ozbek E, Ozpaçaci T (2011) A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses. Nucl Med Commun 32:265–272CrossRef Ozülker T, Ozülker F, Ozbek E, Ozpaçaci T (2011) A prospective diagnostic accuracy study of F-18 fluorodeoxyglucose-positron emission tomography/computed tomography in the evaluation of indeterminate renal masses. Nucl Med Commun 32:265–272CrossRef
5.
Zurück zum Zitat Noda Y, Kanematsu M, Goshima S et al (2015) 18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas. Eur Radiol 25:3009–3016CrossRef Noda Y, Kanematsu M, Goshima S et al (2015) 18-F fluorodeoxyglucose uptake in positron emission tomography as a pathological grade predictor for renal clear cell carcinomas. Eur Radiol 25:3009–3016CrossRef
6.
Zurück zum Zitat Polat EC, Otunctemur A, Ozbek E et al (2014) Standardized uptake values highly correlate with tumour size and Fuhrman grade in patients with clear cell renal cell carcinoma. Asian Pac J Cancer Prev 15:7821–7824CrossRef Polat EC, Otunctemur A, Ozbek E et al (2014) Standardized uptake values highly correlate with tumour size and Fuhrman grade in patients with clear cell renal cell carcinoma. Asian Pac J Cancer Prev 15:7821–7824CrossRef
7.
Zurück zum Zitat Reuter VE (2006) The pathology of renal epithelial neoplasms. Semin Oncol 33:534–543CrossRef Reuter VE (2006) The pathology of renal epithelial neoplasms. Semin Oncol 33:534–543CrossRef
8.
Zurück zum Zitat Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27:612–624CrossRef Cheville JC, Lohse CM, Zincke H, Weaver AL, Blute ML (2003) Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 27:612–624CrossRef
9.
Zurück zum Zitat Hoffmann NE, Gillett MD, Cheville JC, Lohse CM, Leibovich BC, Blute ML (2008) Differences in organ system of distant metastasis by renal cell carcinoma subtype. J Urol 179:474–477CrossRef Hoffmann NE, Gillett MD, Cheville JC, Lohse CM, Leibovich BC, Blute ML (2008) Differences in organ system of distant metastasis by renal cell carcinoma subtype. J Urol 179:474–477CrossRef
10.
Zurück zum Zitat Zisman A, Pantuck AJ, Dorey F et al (2001) Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 19:1649–1657CrossRef Zisman A, Pantuck AJ, Dorey F et al (2001) Improved prognostication of renal cell carcinoma using an integrated staging system. J Clin Oncol 19:1649–1657CrossRef
11.
Zurück zum Zitat Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655–663CrossRef Fuhrman SA, Lasky LC, Limas C (1982) Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol 6:655–663CrossRef
12.
Zurück zum Zitat Delahunt B, Bethwaite PB, Nacey JN (2007) Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype. Pathology 39:459–465CrossRef Delahunt B, Bethwaite PB, Nacey JN (2007) Outcome prediction for renal cell carcinoma: evaluation of prognostic factors for tumours divided according to histological subtype. Pathology 39:459–465CrossRef
13.
Zurück zum Zitat Shuin T, Kondo K, Torigoe S et al (1994) Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumour suppressor gene in primary human renal cell carcinomas. Cancer Res 54:2852–2855PubMed Shuin T, Kondo K, Torigoe S et al (1994) Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumour suppressor gene in primary human renal cell carcinomas. Cancer Res 54:2852–2855PubMed
14.
Zurück zum Zitat Kondo K, Yao M, Yoshida M et al (2002) Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters. Genes Chromosom Cancer 34:58–68CrossRef Kondo K, Yao M, Yoshida M et al (2002) Comprehensive mutational analysis of the VHL gene in sporadic renal cell carcinoma: relationship to clinicopathological parameters. Genes Chromosom Cancer 34:58–68CrossRef
15.
Zurück zum Zitat Kim WY, Kaelin WG (2004) Role of VHL gene mutation in human cancer. J Clin Oncol 22:4991–5004CrossRef Kim WY, Kaelin WG (2004) Role of VHL gene mutation in human cancer. J Clin Oncol 22:4991–5004CrossRef
16.
Zurück zum Zitat Gossage L, Eisen T (2010) Alterations in VHL as potential biomarkers in renal-cell carcinoma. Nat Rev Clin Oncol 7:277–288CrossRef Gossage L, Eisen T (2010) Alterations in VHL as potential biomarkers in renal-cell carcinoma. Nat Rev Clin Oncol 7:277–288CrossRef
17.
Zurück zum Zitat Maxwell PH, Wiesener MS, Chang GW et al (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271–275CrossRef Maxwell PH, Wiesener MS, Chang GW et al (1999) The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis. Nature 399:271–275CrossRef
18.
Zurück zum Zitat Nagashima Y, Kuroda N, Yao N (2013) Transition of organizational category on renal cancer. Jpn J Clin Oncol 43:233–242CrossRef Nagashima Y, Kuroda N, Yao N (2013) Transition of organizational category on renal cancer. Jpn J Clin Oncol 43:233–242CrossRef
19.
Zurück zum Zitat Miyakita H, Tokunaga M, Onda H et al (2002) Significance of 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer. Int J Urol 9:15–18CrossRef Miyakita H, Tokunaga M, Onda H et al (2002) Significance of 18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) for detection of renal cell carcinoma and immunohistochemical glucose transporter 1 (GLUT-1) expression in the cancer. Int J Urol 9:15–18CrossRef
20.
Zurück zum Zitat Maruyama M, Yoshizako T, Uchida K et al (2015) Comparison of utility of tumour size and apparent diffusion coefficient for differentiation of low- and high-grade clear-cell renal cell carcinoma. Acta Radiol 56:250–256CrossRef Maruyama M, Yoshizako T, Uchida K et al (2015) Comparison of utility of tumour size and apparent diffusion coefficient for differentiation of low- and high-grade clear-cell renal cell carcinoma. Acta Radiol 56:250–256CrossRef
21.
Zurück zum Zitat Cornelis F, Tricaud E, Lasserre AS et al (2015) Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma. Eur Radiol 25:24–31CrossRef Cornelis F, Tricaud E, Lasserre AS et al (2015) Multiparametric magnetic resonance imaging for the differentiation of low and high grade clear cell renal carcinoma. Eur Radiol 25:24–31CrossRef
22.
Zurück zum Zitat Alam NA, Rowan AJ, Wortham NC et al (2003) Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 12:1241–1252CrossRef Alam NA, Rowan AJ, Wortham NC et al (2003) Genetic and functional analyses of FH mutations in multiple cutaneous and uterine leiomyomatosis, hereditary leiomyomatosis and renal cancer, and fumarate hydratase deficiency. Hum Mol Genet 12:1241–1252CrossRef
23.
Zurück zum Zitat Isaacs JS, Jung YJ, Mole DR et al (2005) HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8:143–153CrossRef Isaacs JS, Jung YJ, Mole DR et al (2005) HIF overexpression correlates with biallelic loss of fumarate hydratase in renal cancer: novel role of fumarate in regulation of HIF stability. Cancer Cell 8:143–153CrossRef
24.
Zurück zum Zitat Young JR, Margolis D, Sauk S, Pantuck AJ, Sayre J, Raman SS (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology 267:444–453CrossRef Young JR, Margolis D, Sauk S, Pantuck AJ, Sayre J, Raman SS (2013) Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT. Radiology 267:444–453CrossRef
25.
Zurück zum Zitat Jinzaki M, Tanimoto A, Mukai M et al (2002) Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumour angiogenesis. J Comput Assist Tomogr 24:835–842CrossRef Jinzaki M, Tanimoto A, Mukai M et al (2002) Double-phase helical CT of small renal parenchymal neoplasms: correlation with pathologic findings and tumour angiogenesis. J Comput Assist Tomogr 24:835–842CrossRef
26.
Zurück zum Zitat Delahunt B, Sika-Paotonu D, Bethwaite PB et al (2007) Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. Am J Surg Pathol 31:957–960CrossRef Delahunt B, Sika-Paotonu D, Bethwaite PB et al (2007) Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. Am J Surg Pathol 31:957–960CrossRef
Metadaten
Titel
Evaluation of renal cell carcinoma histological subtype and fuhrman grade using 18F-fluorodeoxyglucose-positron emission tomography/computed tomography
verfasst von
Reiko Nakajima
Sayumi Nozaki
Tsunenori Kondo
Yoji Nagashima
Koichiro Abe
Shuji Sakai
Publikationsdatum
18.05.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
European Radiology / Ausgabe 11/2017
Print ISSN: 0938-7994
Elektronische ISSN: 1432-1084
DOI
https://doi.org/10.1007/s00330-017-4875-z

Weitere Artikel der Ausgabe 11/2017

European Radiology 11/2017 Zur Ausgabe

Screening-Mammografie offenbart erhöhtes Herz-Kreislauf-Risiko

26.04.2024 Mammografie Nachrichten

Routinemäßige Mammografien helfen, Brustkrebs frühzeitig zu erkennen. Anhand der Röntgenuntersuchung lassen sich aber auch kardiovaskuläre Risikopatientinnen identifizieren. Als zuverlässiger Anhaltspunkt gilt die Verkalkung der Brustarterien.

S3-Leitlinie zu Pankreaskrebs aktualisiert

23.04.2024 Pankreaskarzinom Nachrichten

Die Empfehlungen zur Therapie des Pankreaskarzinoms wurden um zwei Off-Label-Anwendungen erweitert. Und auch im Bereich der Früherkennung gibt es Aktualisierungen.

Fünf Dinge, die im Kindernotfall besser zu unterlassen sind

18.04.2024 Pädiatrische Notfallmedizin Nachrichten

Im Choosing-Wisely-Programm, das für die deutsche Initiative „Klug entscheiden“ Pate gestanden hat, sind erstmals Empfehlungen zum Umgang mit Notfällen von Kindern erschienen. Fünf Dinge gilt es demnach zu vermeiden.

„Nur wer sich gut aufgehoben fühlt, kann auch für Patientensicherheit sorgen“

13.04.2024 Klinik aktuell Kongressbericht

Die Teilnehmer eines Forums beim DGIM-Kongress waren sich einig: Fehler in der Medizin sind häufig in ungeeigneten Prozessen und mangelnder Kommunikation begründet. Gespräche mit Patienten und im Team können helfen.

Update Radiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.